arrow
Z

Zhifeng Sheng

Central South University
H指数:22
被引数:2,214

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia® in Chinese postmenopausal women with osteoporosis

CMAB807(一种denosumab生物类似物)相对于Prolia®在患有骨质疏松的中国绝经后女性中的疗效与安全性

2025-09-190
PRE
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebocontrolled, dose-escalation phase 1 trial
2023-04-053
OAAI